Uveitis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Uveitis is a broad term that refers to a group of inflammatory diseases that cause swelling and destroy eye tissues. These diseases can cause minor vision loss or severe vision loss. · According to one estimate, chronic, non-infectious posterior uveitis affects 175,000 people in the United States and 800,000 people worldwide. Thelansis’s “Uveitis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Uveitis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs insights of Uveitis across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study....